Compare PHC Holdings Corp. with Similar Stocks
Dashboard
1
With a growth in Operating Profit of 37.83%, the company declared Outstanding results in Jun 26
- OPERATING CASH FLOW(Y) Highest at JPY 51,406 MM
- INTEREST COVERAGE RATIO(Q) Highest at 685.68
- RAW MATERIAL COST(Y) Fallen by -4.51% (YoY)
2
With ROCE of 5.90%, it has a very attractive valuation with a 0.93 Enterprise value to Capital Employed
Stock DNA
Pharmaceuticals & Biotechnology
JPY 140,306 Million (Small Cap)
40.00
NA
0.00%
1.24
0.14%
0.87
Revenue and Profits:
Net Sales:
90,672 Million
(Quarterly Results - Jun 2026)
Net Profit:
6,293 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.2%
0%
30.2%
6 Months
33.01%
0%
33.01%
1 Year
33.79%
0%
33.79%
2 Years
23.23%
0%
23.23%
3 Years
-12.67%
0%
-12.67%
4 Years
-12.56%
0%
-12.56%
5 Years
0%
0%
0.0%
PHC Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
21.45%
EBIT Growth (5y)
64.68%
EBIT to Interest (avg)
1.52
Debt to EBITDA (avg)
4.65
Net Debt to Equity (avg)
1.53
Sales to Capital Employed (avg)
0.88
Tax Ratio
97.77%
Dividend Payout Ratio
1,079.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.64%
ROE (avg)
1.83%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.84
EV to EBIT
15.72
EV to EBITDA
6.91
EV to Capital Employed
0.93
EV to Sales
0.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.90%
ROE (Latest)
2.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
90,672.00
95,152.00
-4.71%
Operating Profit (PBDIT) excl Other Income
16,470.00
11,485.00
43.40%
Interest
2,402.00
1,805.00
33.07%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,293.00
-315.00
2,097.78%
Operating Profit Margin (Excl OI)
107.90%
48.80%
5.91%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is -4.71% vs -0.76% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 2,097.78% vs -125.69% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
364,403.00
361,593.00
0.78%
Operating Profit (PBDIT) excl Other Income
47,712.00
49,791.00
-4.18%
Interest
6,166.00
5,262.00
17.18%
Exceptional Items
66.00
54.00
22.22%
Consolidate Net Profit
219.00
10,364.00
-97.89%
Operating Profit Margin (Excl OI)
56.50%
60.60%
-0.41%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 0.78% vs 2.17% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -97.89% vs 180.61% in Mar 2025
About PHC Holdings Corp. 
PHC Holdings Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






